Generated: December 15, 2017
DrugPatentWatch Database Preview
Theophylline - Generic Drug Details
« Back to Dashboard
What are the generic drug sources for theophylline and what is the scope of theophylline patent protection?
is the generic ingredient in fifty-two branded drugs marketed by Fleming Pharms, Forest Labs, Sanofi Aventis Us, Graham Dm, Actient Pharms, Auxilium Pharms Inc, Auxilium Pharms Llc, Schering, Whitby, Schwarz Pharma, Ortho Mcneil Pharm, Cent Pharms, Hospira, Inwood Labs, Sandoz, Scherer Rp, Fisons, Kv Pharm, Cenci, Lannett, Panray, Alpharma Us Pharms, Chartwell Rx, Halsey, Pharm Assoc, Precision Dose, Roxane, Taro, Wockhardt, B Braun, Baxter Hlthcare, Hospira Inc, Nostrum Labs Inc, 3M, Silarx, Tris Pharma Inc, Ferndale Labs, Warner Chilcott, Monarch Pharms, Roerig, Pharm Res Assoc, Nostrum Pharms Llc, Able, Alembic Pharms Ltd, Glenmark Generics, Mylan Ireland Ltd, Pliva, Rhodes Pharms, Teva Pharms, Medicis, and Novartis, and is included in one hundred and nineteen NDAs. Additional information is available in the individual branded drug profile pages.
There are thirty-six drug master file entries for theophylline. Thirty suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for theophylline
|Ortho Mcneil Pharm||THEOPHYL-225||theophylline||ELIXIR;ORAL||086485-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Cenci||ELIXOMIN||theophylline||ELIXIR;ORAL||088303-001||Jan 25, 1984||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Medicis||THEOLAIR||theophylline||TABLET;ORAL||086399-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Schering||THEO-DUR||theophylline||TABLET, EXTENDED RELEASE;ORAL||085328-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Forest Labs||DURAPHYL||theophylline||TABLET, EXTENDED RELEASE;ORAL||088505-001||Apr 3, 1985||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Forest Labs||DURAPHYL||theophylline||TABLET, EXTENDED RELEASE;ORAL||088503-001||Apr 3, 1985||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Sanofi Aventis Us||SLO-PHYLLIN||theophylline||CAPSULE, EXTENDED RELEASE;ORAL||085203-001||May 24, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Scherer Rp||THEOPHYLLINE||theophylline||CAPSULE;ORAL||084731-002||Nov 7, 1986||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Graham Dm||SOMOPHYLLIN-CRT||theophylline||CAPSULE, EXTENDED RELEASE;ORAL||087763-001||Feb 27, 1985||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Taro||THEOPHYLLINE||theophylline||ELIXIR;ORAL||089626-001||Oct 28, 1988||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Expired Orange Book Patents for Generic Ingredient: theophylline
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.